Table 1 Overview of uniform research case definition criteria18 in confirmed, probable and possible TBM cases.

From: High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China

Diagnostic categories and criteria (Maximum category score)

Diagnostic score

Confirmed n = 25 (%)

Probable n = 84 (%)

Possible n = 239(%)

Clinical (Maximum score = 6)

 CNS symptom duration >5 days

4

25 (100.0)

67 (79.8)

159 (66.5)

 Other symptoms suggestive of TB a

2

19 (76.0)

43 (51.2)

31 (13.0)

 Recent close contact with an infectious TB case b or positive TST/IGRA

2

11 (44.0)

9 (10.7)

5 (2.1)

 Focal neurological deficit c

1

14 (56.0)

34 (40.5)

95 (39.7)

 Cranial nerve palsy

1

4 (16.0)

5 (6.0)

24 (10.0)

 Altered consciousness

1

18 (72.0)

45 (53.6)

108 (45.2)

CSF (Maximum score = 4)

 Clear appearance

1

18 (72.0)

77 (91.7)

221(92.5)

 Cells: 10–500 per μl

1

24 (96.0)

72 (85.7)

210 (87.9)

 Lymphocytic predominance (>50%)

1

14 (56.0)

61 (72.6)

192 (80.3)

 Protein concentration greater than 1 g/L

1

17 (68.0)

54 (64.3)

72 (30.1)

 Glucose concentration <2.2 mmol/L

1

22 (88.0)

52 (61.9)

53 (22.2)

CNS imaging (Maximum score = 6)

 Hydrocephalus

1

11 (44.0)

22 (26.2)

27 (11.3)

 Basal meningeal enhancement

2

9 (36.0)

18 (21.4)

23 (9.6)

 Tuberculoma

2

3 (12.0)

1 (1.2)

0

 Infarct

1

6 (24.0)

6 (7.1)

11 (4.6)

 Pre-contrast basal hyperdensity

2

4 (16.0)

12 (14.3)

8 (3.3)

TB elsewhere (Maximum score = 4)

 CXR suggestive (PTB = 2; miliary TB = 4)

2/4

19 (76.0)

43 (51.2)

31(13.0)

 Other imaging suggestive of TB

2

11 (44.0)

9 (10.7)

5 (2.1)

 Positive AFB, M. tuberculosis or NAAT from extra-neural specimen

4

4 (16.0)

5 (6.0)

2 (0.8)

Score; median (range)

20 max

13 (6–20)

12 (10–18) d

6 (6–11) e

  1. TBM-tuberculous meningitis; TB-tuberculosis; PTB-pulmonary TB: TST-Tuberculin Skin Test; IGRA-Interferon Gamma Release Assay; CSF-Cerebral Spinal Fluid; CNS-Central Nervous System; CXR-Chest X-ray; AFB-Acid Fast Bacilli; NAAT-commercial Nucleic Acid Amplification Test.
  2. aWeight loss (or poor weight gain in children), night sweats, or persistent cough for more than 2 weeks.
  3. bHistory of recent (within past year) close contact with an individual with pulmonary TB.
  4. cExcluding cranial nerve palsies.
  5. dScores of 10 and 11 when brain imaging was not available.
  6. eScores of 10 and 11 when brain imaging was available.